Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Compositions and methods for the treatment of thyroid eye disease 2023-5-10 2023-5-29
Compositions and methods for treatment of thyroid eye disease 2023-1-06 2023-8-31
Compositions and methods for treatment of thyroid eye disease 2023-1-06 2023-8-10
Compositions and methods for treatment of thyroid eye disease 2022-12-22 2023-6-29
Compositions, doses, and methods for treatment of thyroid eye disease 2022-8-10 2023-2-16
miR-155 INHIBITORS FOR TREATING CUTANEOUS T CELL LYMPHOMA (CTCL) 2020-3-25 2020-6-18
Polynucleotide conjugates and uses thereof 2020-3-05 2020-10-08
Treatment of adult t cell leukemia/lymphoma (atll) using mir-155 inhibitors 2019-5-15 2022-2-24
Mir-92 inhibitors and uses thereof 2019-3-13 2019-6-27
Mir29 mimics for the treatment of ocular fibrosis 2018-11-30 2021-10-06
Mir-29 mimics and uses thereof 2018-6-07 2019-5-02
Mir-92 inhibitors for treatment of heart failure 2018-3-23 2020-2-05
Oligonucleotide-based inhibitors comprising locked nucleic acid motif 2017-9-13 2019-7-02 2019-7-02
Inhibitors of myh7b and uses thereof 2017-8-24 2018-4-05
Methods for treating cutaneous t-cell lymphoma (ctcl) with mir-155 inhibitors 2017-7-07 2020-3-25
Mir-19 modulators and uses thereof 2016-9-22 2017-3-30
Mir-155 inhibitors for treating amyotrophic lateral sclerosis (als) 2016-6-03 2019-1-02
Mirna mimetics and their use in treating sensory conditions 2016-3-16 2016-9-22
Synthesis of bicyclic nucleosides 2015-3-16 2017-1-25
System and Method for Classification of Patients 2014-11-20 2015-6-04
Bridged bicyclic nucleosides 2014-3-16 2018-1-10 2018-1-10
Locked nucleic acid inhibitor of mir-145 and uses thereof 2014-3-13 2016-1-20
Microrna inhibitors comprising locked nucleotides 2013-12-16 2014-7-03
Chemical modification motifs for mirna inhibitors and mimetics 2013-8-22 2014-3-06
Inhibitors of the mir-15 family of micro-rnas 2013-6-21 2015-4-29
Control of whole body energy homeostasis by microRNA regulation 2012-10-09 2016-8-30 2016-8-30
Micro-RNA for the regulation of cardiac apoptosis and contractile function 2012-3-16 2014-10-28 2014-10-28
Blood-borne miRNA as surrogate markers of drug efficacy for cardiac conditions 2011-12-15 2013-10-23
Base modified oligonucleotides 2011-11-07 2013-9-11
Gene Marker Sets And Methods For Classification Of Cancer Patients 2011-9-29 2013-12-12
Lipophilic Polynucleotide Conjugates 2010-5-05 2012-5-24
Micro-RNA Mediated Modulation of Colony Stimulating Factors 2009-7-24 2012-5-10